Literature DB >> 170312

Antibodies to Epstein-Barr virus in patients with cryptococcosis.

P H Levine, R D Diamond, J I Reisher.   

Abstract

Antibody levels to the Epstein-Barr virus, the etiological agent for heterophile-positive infectious mononucleosis, have been demonstrated in high titer in a number of lymphomas as well as infectious mononucleosis. Recent reports have suggested that the elevated antibody levels to Epstein-Barr virus may be the nonspecific result of disordered cell-mediated immunity. This study of patients with cryptococcosis was therefore undertaken to examine another disorder of known etiology associated with a defect in cell-mediated immunity. In this study we found that antibody levels in cryptococcosis patients, including a group specifically demonstrated to be anergic to a series of skin test antigens, were no different than those in matched normal controls. At the present time, therefore, it is unlikely that elevated antibody levels can be explained solely on the basis of depressed cellular immunity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170312      PMCID: PMC275093          DOI: 10.1128/jcm.1.4.363-365.1975

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; B G ACHONG; Y M BARR
Journal:  Lancet       Date:  1964-03-28       Impact factor: 79.321

2.  Antibodies to Epstein-Barr virus-associated antigens in relatives of cancer patients.

Authors:  P H Levine; J F Fraumeni; J I Reisher; D E Waggoner
Journal:  J Natl Cancer Inst       Date:  1974-04       Impact factor: 13.506

3.  Antibody to Epstein-Barr virus and cellular immunity in Hodgkin's disease and chronic lymphatic leukemia.

Authors:  J Hesse; E Andersen; P H Levine; P Ebbesen; P Halberg; J I Reisher
Journal:  Int J Cancer       Date:  1973-01-15       Impact factor: 7.396

4.  Sarcoidosis, another disease associated with serologic evidence for herpes-like virus infection.

Authors:  Y Hirshaut; P Glade; B D Vieira; E Ainbender; B Dvorak; L E Siltzbach
Journal:  N Engl J Med       Date:  1970-09-03       Impact factor: 91.245

5.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

6.  Seroepidemiologic studies of infectious mononucleosis with EB virus.

Authors:  A S Evans; J C Niederman; R W McCollum
Journal:  N Engl J Med       Date:  1968-11-21       Impact factor: 91.245

7.  Serology of human cryptococcosis.

Authors:  D D Bindschadler; J E Bennett
Journal:  Ann Intern Med       Date:  1968-07       Impact factor: 25.391

8.  Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies.

Authors:  J C Niederman; R W McCollum; G Henle; W Henle
Journal:  JAMA       Date:  1968-01-15       Impact factor: 56.272

9.  Experience with a new skin test antigen prepared from Cryptococcus neoformans.

Authors:  A J Atkinson; J E Bennett
Journal:  Am Rev Respir Dis       Date:  1968-04

10.  Differential reactivity of human serums with early antigens induced by Epstein-Barr virus.

Authors:  W Henle; G Henle; B A Zajac; G Pearson; R Waubke; M Scriba
Journal:  Science       Date:  1970-07-10       Impact factor: 47.728

View more
  1 in total

1.  Identification of Multiple Cryptococcal Fungicidal Drug Targets by Combined Gene Dosing and Drug Affinity Responsive Target Stability Screening.

Authors:  Yoon-Dong Park; Wei Sun; Antonio Salas; Avan Antia; Cindy Carvajal; Amy Wang; Xin Xu; Zhaojin Meng; Ming Zhou; Gregory J Tawa; Jean Dehdashti; Wei Zheng; Christina M Henderson; Adrian M Zelazny; Peter R Williamson
Journal:  MBio       Date:  2016-08-02       Impact factor: 7.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.